Pharmacovigilance [Pharmacovigilance].
Details
Request a copy Under indefinite embargo.UNIL restricted access
State: Public
Version: Final published version
Serval ID
serval:BIB_D7E6ACB41846
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Pharmacovigilance [Pharmacovigilance].
Journal
Revue Médicale Suisse
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
2012
Volume
8
Number
324
Pages
116-119
Language
french
Notes
Publication types: English Abstract ; Journal Article ; Review Publication Status: ppublish
Abstract
Main pharmacovigilance updates in 2011 are reviewed. Dronedarone: Serious cardio-vascular and hepatic adverse reactions for a questionable efficacy. Long-term proton pump inhibitors: A cause of hypomagnesemia. Bisphosphonates: A risk of atypical femoral fractures. Dasatinib: Cases of pulmonary arterial hypertension reported. Lenalidomide: A risk of second primary malignancies. Daptomycine: Cases of eosinophilic pneumonia reported. Tigecycline: Inferior to comparators. Drotrecogin alfa: Market withdrawal due to lack of efficacy. Nimesulide: More hepatotoxic than other NSAIDs. Topiramate: Evidence of teratogenicity (oral clefts). Valproate: Impaired cognitive development in addition to well-known teratogenicity. Antipsychotics in late pregnancy: A risk of neonatal complications.
Keywords
Adverse Drug Reaction Reporting Systems, Drug-Related Side Effects and Adverse Reactions, Female, Hospitals, University, Humans, Pharmacovigilance, Switzerland
Pubmed
Create date
30/07/2013 14:13
Last modification date
20/08/2019 16:57
Usage data
